A journal has issued an expression of concern (EOC) for a recently published study after a probe identified “problems with the figure presentation.”
According to the EOC notice in New Phytologist, two figures in the paper contained “some anomalies,” and the corresponding author has acknowledged that there are problems with the images.
Here’s the EOC notice: Continue reading Plant journal flags fungus paper amid investigation
After researchers in China included the same images in two papers published online one month apart, one paper has been retracted, and the other flagged with an expression of concern.
According to the retraction notice in the International Journal of Molecular Medicine (IJMM), the authors intended that the two different papers offered “different research perspectives.”
Meanwhile, the Chinese Medical Journal — which published the same images one month later — has issued an expression of concern (EOC), noting it “should not be considered as a statement regarding the validity of the work.” Both papers describe how cells regulate blood flow to the retina.
Normally, journals choose to retract the most recent paper containing duplicated images, but in this case, the IJMM paper was published online in February 2016, and the Chinese Medical Journal in March.
Here’s the retraction notice: Continue reading Authors use same images in two studies — one is retracted, the other flagged by journal
In November, a vice president at an institution in Taiwan retracted a hotly debated cancer paper from Nature Cell Biology, citing image problems including duplications. Now, the Journal of Biological Chemistry has done the same, again citing image duplications.
There are a few things to note about the latest retraction: One, the last author is again Kuo Min-liang — who holds an appointment at National Taiwan University (NTU), and is also a vice president at Kaohsiung Medical University in Taiwan. Kuo is currently facing allegations that he accepted bribes to add co-authors to his papers; NTU told us it is investigating the latest retraction in the Journal of Biological Chemistry, including Kuo.
The other notable feature of the retraction is the notice itself, which lists a remarkable number of duplicated images. Take a look:
Continue reading Prominent researcher in Taiwan loses another paper for image duplication
A researcher in Germany has logged her fourth retraction following an investigation by her former employer that found evidence of scientific misconduct.
The latest retraction for Tina Wenz in the Journal of Applied Physiology mentions the probe at the University of Cologne in Germany, which recommended retracting six of her papers. One had already been retracted by the time the report was released; last month, we reported that two others had been pulled. Now, we’ve come across a fourth.
Here’s the latest retraction notice: Continue reading Researcher loses 4th paper flagged by misconduct probe
Following a journal probe and questions on PubPeer about their work, authors in Spain have issued four corrections, citing missing raw data for experiments conducted more than 10 years ago.
All papers include the same last two authors, Mireia Duñach at the Autonomous University of Barcelona, and Antonio García de Herreros at the Institut Hospital del Mar d’Investigacions Mèdiques.
Three of the corrections were issued by the Journal of Biological Chemistry, from which the authors retracted three papers earlier this year after a journal investigation concluded they contain reused images, designed to represent different experiments.
Duñach told us the latest corrections are the result of her own initiation:
Continue reading Authors in Spain issue string of corrections
A pathology journal is retracting two papers after an investigation at the last author’s institution in Germany found evidence of scientific misconduct.
The notice for both papers cites an investigation involving Regine Schneider-Stock, who studies cancer biology at the Friedrich Alexander-University Erlangen-Nuremberg (FAU). Meanwhile, another 2005 paper that lists Schneider-Stock as the first author was retracted in October, noting evidence of image manipulation.
The most recent retractions, from the American Journal of Pathology, note that FAU declined to provide the journal with details of its investigation beyond a prepared statement:
Continue reading Cancer researcher in Germany loses multiple papers after misconduct finding
Authors have retracted a JAMA article summarizing the evidence behind the benefits of a supplement, after the systemic review upon which it was based was withdrawn.
The 2014 paper, “Oral Zinc for the Common Cold,” drew from a 2013 Cochrane Review, considered the gold standard for rigorous analyses of clinical treatments. That Cochrane review was withdrawn last year, a decision that the editors upheld this past September. Both were co-authored by Rashmi Ranjan Das, of the All India Institute of Medical Sciences, in Bhubaneswar, and Meenu Singh, of the Post-Graduate Institute of Medical Education and Research, in Chandigarh, India.
JAMA editor in chief Howard Bauchner told Retraction Watch that this week’s retraction followed an investigation by the journal: Continue reading JAMA article on zinc for the common cold retracted
Journals published by the European Molecular Biology Organization (EMBO) have retracted a handful of figures in two papers with the same last and first authors.
After some figures in the 2005 and 2007 papers were flagged on PubPeer and the authors couldn’t provide the original data, the journals decided to retract parts of the papers, since other data supported the remaining conclusions, according to the Head of Scientific Publications at EMBO.
The partial retractions are labeled as corrigenda by the journals. Earlier this year, the U.S. National Library of Medicine (NLM) announced it would be classifying partial retractions as errata, noting they had been used so rarely by journals.
Both lengthy corrigenda (also reported by Leonid Schneider) contain statements from the authors and the editors. The statements from the authors provide detailed explanations about the problems with the figures in question; here’s an excerpt from the editor’s statement in The EMBO Journal corrigendum: Continue reading EMBO journals retract figures in two papers missing source data
The authors of a highly cited 2015 paper in Nature Materials have retracted it, after being unable to reproduce some of the key findings.
The move prompted the journal to also retract an associated News & Views article.
Here’s the retraction notice for “Fast and long-range triplet exciton diffusion in metal–organic frameworks for photon upconversion at ultralow excitation power:” Continue reading Lack of reproducibility triggers retractions of Nature Materials articles
2013 probably felt like it was going to be a great year for stem cell biologist Douglas Melton at Harvard. He had published a buzz-worthy paper in Cell about a new way to potentially boost insulin in diabetics, attracting significant media attention, and eventually gathering nearly 200 citations.
But 2016 is closing out on a less positive tone for Melton — today, he and his colleagues are retracting the paper, after multiple labs (including his own) couldn’t reproduce the findings.
Although the lab has itself already published two articles casting doubt on the original findings, Melton told Retraction Watch he chose to retract the paper to ensure there was no confusion about the original paper’s validity: Continue reading Harvard biologist retracts diabetes breakthrough in Cell